Amino-Terminal Pro-B-Type Natriuretic Peptide Testing for Inpatient Monitoring and Treatment Guidance of Acute Destabilized Heart Failure

American Journal of Cardiology

Volumn 101, Issue 3 SUPPL., 2008, Pages

  Bettencourt, Paulo ^a   Januzzi Jr , James L ^b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CLINICAL EVALUATION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITAL PATIENT; HOSPITALIZATION; LABORATORY TEST; OBSERVATIONAL METHOD; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HEART FAILURE; HUMANS; INPATIENTS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX;

EID: 38649122074     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.026     Document Type: Article

References (27)

1. Heart Failure Society of America. Evaluation and management of patients with acute decompensated heart failure. J Card Fail 12 (2006) e86-e103
2. Nieminen M.S., Bohm M., Cowie M.R., Drexler H., Filippatos G.S., Jondeau G., Hasin Y., Lopez-Sendon J., Mebazaa A., Metra M., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
3. Al-Meslmani B.M., Fahoum S.K., and Shamia M.G. NT-proBNP in monitoring treatment of patients with congestive heart failure. Clin Lab 53 (2007) 35-39
4. Bayes-Genis A., Pascual-Figal D., Fabregat J., Domingo M., Planas F., Casas T., Ordonez-Llanos J., Valdes M., and Cinca J. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol 120 (2007) 338-343
5. Bayes-Genis A., Santalo-Bel M., Zapico-Muniz E., Lopez L., Cotes C., Bellido J., Leta R., Casan P., and Ordonez-Llanos J. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 6 (2004) 301-308
6. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., and Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
7. Cioffi G., Tarantini L., Stefenelli C., Azzetti G., Marco R., Carlucci S., and Furlanello F. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function. J Card Fail 12 (2006) 608-615
8. Knebel F., Schimke I., Pliet K., Schattke S., Martin S., Borges A.C., and Baumann G. NT-proBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation. J Card Fail 11 suppl (2005) S38-S41
9. Logeart D., Thabut G., Jourdain P., Chavelas C., Beyne P., Beauvais F., Bouvier E., and Solal A.C. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641
10. Chen A.A., Wood M.J., Krauser D.G., Baggish A.L., Tung R., Anwaruddin S., Picard M.H., and Januzzi J.L. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 27 (2006) 839-845
11. Gegenhuber A., Mueller T., Dieplinger B., Poelz W., Pacher R., and Haltmayer M. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clin Chim Acta 370 (2006) 174-179
12. Hartmann F., Packer M., Coats A.J., Fowler M.B., Krum H., Mohacsi P., Rouleau J.L., Tendera M., Castaigne A., Anker S.D., et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110 (2004) 1780-1786
13. Januzzi Jr. J.L., Sakhuja R., O'Donoghue M., Baggish A.L., Anwaruddin S., Chae C.U., Cameron R., Krauser D.G., Tung R., Camargo Jr. C.A., and Lloyd-Jones D.M. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med 166 (2006) 315-320
14. Januzzi J.L., van Kimmenade R., Lainchbury J., Bayes-Genis A., Ordonez-Llanos J., Santalo-Bel M., Pinto Y.M., and Richards M. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. The International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
15. Masson S., Latini R., Anand I.S., Vago T., Angelici L., Barlera S., Missov E.D., Clerico A., Tognoni G., and Cohn J.N. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 52 (2006) 1528-1538
16. Di Somma S., Magrini L., Mazzone M., De Leva R., Tabacco F., Marino R., Talucci V., Ferri E., Forte P., Cardelli P., Gentiloni N., and Pittoni V. Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure. Am J Emerg Med 25 (2007) 335-339
17. Feola M., Menardi E., Ribichini F., Vado A., Deorsola A., Ferrero V., Visconti G., Milanese U., and Uslenghi E. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure. Med Sci Monit 9 (2003) CR341-CR345
18. Fitzgerald R.L., Cremo R., Gardetto N., Chiu A., Clopton P., Bhalla V., and Maisel A.S. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure. Am Heart J 150 (2005) 471-477
19. Kohno M., Minami M., Kano H., Yasunari K., Maeda K., Hanehira T., and Yoshikawa J. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left ventricular hypertrophy. Metabolism 49 (2000) 1356-1360
20. Yasumura Y., Miyatake K., Okamoto H., Miyauchi T., Kawana M., Tsutamoto T., Kitakaze M., Matsubara H., Takaoka H., Anzai T., et al. Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure. Circ J 68 (2004) 361-366
21. Maisel A., Hollander J.E., Guss D., McCullough P., Nowak R., Green G., Saltzberg M., Ellison S.R., Bhalla M.A., Bhalla V., Clopton P., and Jesse R. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 (2004) 1328-1333
22. Corell P., Gustafsson F., Kistorp C., Madsen L.H., Schou M., and Hildebrandt P. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure. Int J Cardiol 117 (2007) 395-402
23. Morello A., Lloyd-Jones D.M., Chae C.U., van Kimmenade R.R., Chen A.C., Baggish A.L., O'Donoghue M., Lee-Lewandrowski E., and Januzzi Jr. J.L. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 153 (2007) 90-97
24. Braunschweig F., Fahrleitner-Pammer A., Mangiavacchi M., Ghio S., Fotuhi P., Hoppe U.C., and Linde C. Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure. Eur J Heart Fail 8 (2006) 797-803
25. Schou M., Gustafsson F., Nielsen P.H., Madsen L.H., Kjaer A., and Hildebrandt P.R. Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. Eur J Heart Fail 9 (2007) 68-74
26. Wu A.H. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J 152 (2006) 828-834
27. Wu A.H., Smith A., Wieczorek S., Mather J.F., Duncan B., White C.M., McGill C., Katten D., and Heller G. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92 (2003) 628-631